Resize text 
Resize text 
Publications and PresentationsThis page includes reports of the work packages, scientific papers published as a result of this project, conference presentations about the project and general information, e.g. project presentation, posters and relevant papers by partners, etc. For key achievements of the Consortium work, please see: Results |
» Scientific Papers
» Conference Presentations
» General Information
Belitser, S. V., Martens, E. P., Pestman, W. R., Groenwold, R. H., de Boer, A. and Klungel, O. H. (2011), Measuring balance and model selection in propensity score methods. Pharmacoepidemiology and Drug Safety. doi: 10.1002/pds.2188. |
| Groenwold R, Klungel O, Grobbee D, Hoes A. Selection of confounding variables should not be based on observed associations with exposure, Eur J Epidemiol. DOI 10.1007/s10654-011-9606-1. |
| Groenwold RH, de Vries F, de Boer A, Pestman WR, Rutten FH, Hoes AW, Klungel OH. Balance measures for propensity score methods: a clinical example on beta-agonist use and the risk of myocardial infarction, Pharmacoepidemiology and Drug Safety. Doi: 10.1002/pds.2251. |
| Anna Jamry- Dziurla -Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium - finding new ways of communicating with pregnant women to monitor the pragnancy, VII Women's Health Forum, Teaching and Scientific Conference, Kalisz, 02 December 2011 |
| Anna Jamry- Dziurla - Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium - finding new ways of communicating with pregnant women to monitor the pragnancy, 2nd International Conference - Promotion of Reproductive Health, Poznan, 4-5 November 2011 |
| Marie Dupuch – Grouping pharmacovigilance terms with semantic distance – MIE, 23rd International Conference of EFMI, Oslo, 28 August 2011 |
| V Abbing-Karahagopian – Bridging Differences in Findings from Observational Pharmacoepidemiological Studies: The Design and Rationale of Work Package 2 of the PROTECT Project – 27th ICPE, 14-17 August 2011, Pharmacoepidemiology and Drug Safety, 20: S1–S364. doi: 10.1002/pds.2206 |
| M Sabaté – Finding databases on Drug Utilization Information across Europe. What kind of data do they provide? – 27th ICPE, Chicago, 14-17 August 2011, Pharmacoepidemiology and Drug Safety, 20: S1–S364. doi: 10.1002/pds.2206 |
| T Bergvall – Fuzzy text matching to identify known adverse drug reactions – 27th ICPE, Chicago, 14-17 August 2011, Pharmacoepidemiology and Drug Safety, 20: S1–S364. doi: 10.1002/pds.2206 |
| S Belitzer – Measuring balance and model selection in propensity score methods – 27th ICPE, Chicago, 14-17 August 2011, Pharmacoepidemiology and Drug Safety, 20: S1–S364. doi: 10.1002/pds.2206 |
| Rolf Groenwold – Balance measures for propensity score methods: a clinical example on beta-agonist use and the risk of myocardial infarction – 27th ICPE, Chicago,14-17 August 2011, Pharmacoepidemiology and Drug Safety, 20: S1–S364. doi: 10.1002/pds.2206 |
| Phuong T Khong – Potential impact of benzodiazepine use on the rate of hip fractures in Denmark, the Netherlands and Norway – 27th ICPE, Chicago, 14-17 August 2011, Pharmacoepidemiology and Drug Safety, 20: S1–S364. doi: 10.1002/pds.2206 |
| Jennifer SB Goldenberg – Potential population impact of antidepressant use on hip fractures rate in Denmark, Norway and the Netherlands – 27th ICPE, Chicago, 14-17 August 2011, Pharmacoepidemiology and Drug Safety, 20: S1–S364. doi: 10.1002/pds.2206 |
| Laurent Auclert - PROTECT-Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium, Seminaire IFIS, Paris, 05 July 2011 |
Marie Dupuch – Distance Sémantique pour intensifier le signal en pharmacovigilance – TALN, 18ème edition du traitement automatique des langues naturelles, Montpellier, 27 June 2011 |
Alain Mickaleff- The PROTECT Consortium - Visualizing Benefit- Risk , CIRS- Annual Meeting, Washington, 16-17 June 2011 |
Deborah Ashby – Benefit-Risk Integration and Representation – CHMP ORGAM 9 June 2011 |
Olaf Klungel - Improved control for confounding using propensity scores and instrumental variables? - 2nd Bordeaux Pharmacoepi Festival. 23-25 May 2011 |
Xavier Kurz – PROTECT Project general status update- IMI Stakeholder meeting, Budapest, 12 May 2011 |
Deborah Ashby - Current methodological approaches to risk-benefit decision-making – DIA EuroMeeting, Geneva, 28-30 March 2011 |
Liz Swain - Innovation through Consortia: The IMI PROTECT Project – DIA EuroMeeting, Geneva, 28-30 March 2011 |
| Pierre-Yves Lastic - Global presentation on Protect (status update February 2011) - ORACLE Health sciences innovation forum 5th, 22 March 2011 |
Stefanie Prilla - PROTECT - Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium, Status update: October 2010- Meeting of the EMA’s Healthcare Professionals' Working Group, 4th March 2011 |
Jim Slattery - Comparison of methods for identification of adverse drug reactions from spontaneous report datasets - The Second International Symposium on Biopharmaceutical Statistics, Bridging Drug Development from Research to Marketing , 1-3 March 2011 |
Bharat Thakrar - Detecting drug-drug interactions in spontaneous report datasets - The Second International Symposium on Biopharmaceutical Statistics, Bridging Drug Development from Research to Marketing , 1-3 March 2011 |
Suzie Seabroke - Stratification and subgrouping in spontaneous report datasets - The Second International Symposium on Biopharmaceutical Statistics, Bridging Drug Development from Research to Marketing , 1-3 March 2011 |
Niklas Norén - Statistical pattern discovery for medical outcomes in electronic patient records -The Second International Symposium on Biopharmaceutical Statistics, Bridging Drug Development from Research to Marketing , 1-3 March 2011 |
Xavier Kurz - The PROTECT Project: an Innovative Public-Private Partnership for New Methodologies in Pharmacovigilance and Pharmacoepidemiology - Brookings Active Surveillance Implementation Council Meeting, The Brookings Institution, Washington, US, 18 November 2010 |
Xavier Kurz - The future of benefit/risk assessment in Europe: The PROTECT programme - Symposium ‘Relativity in the Evaluation of Medicines’, LASER, Wallace Collection, 15 November 2010 |
Peter Arlett - The PROTECT Project: an Innovative Public-Private Partnership for New Methodologies in Pharmacovigilance and Pharmacoepidemiology - ISOP Ghana Nov 2010 |
Xavier Kurz - PROTECT Project - Progress status - CHMP's Pharmacovigilance Working Party at the EMA, London, UK , 22 September 2010 |
Rebecca Buckley - The role of different interest organizations in the European Medicines Agency - The Role of Patient and Professional Organizations for EU Health Governance, Brussels, Belgium, 21-22 September 2010 |
Xavier Kurz, Stella Blackburn - The Alternative Life of Regulators (including a general presentation of PROTECT and WP4) - 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Brighton, UK, 19-22 August 2010, Pharmacoepidemiology and Drug Safety, 19: S1–S347. doi: 10.1002/pds.2019. |
Luisa Ibanez - Research Working Groups on Drug Utilization Across Europe - 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Brighton, UK , 19-22 August 2010, Pharmacoepidemiology and Drug Safety, 19: S1–S347. doi: 10.1002/pds.2019 |
Xavier Kurz - The Innovative Medicines Initiative and the PROTECT project - EudraVigilance Information Day at the EMA, London, UK, 22 June 2010 |
Xavier Kurz - The Innovative Medicines Initiative and the PROTECT project - International Postmarketing Surveillance Discussion, via VTC, 18 June 2010 |
Xavier Kurz - PROTECT - Pharmacoepidemiological Research on Outcomes of Therapeutics by an European ConsorTium - IMI stakeholders forum, 15 June 2010 |
Liz Swain - PROTECT - Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium - Eu2P general assembly, May 2010 |
Stella Blackburn - PROTECT - Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium, Post-approval summit,Boston, US, 11-12 May 2010 |
Nancy Dreyer - WP4: Exploratory Study of Self-Reported Medication Use in Pregnant Women - Post-approval summit, Boston, US, 11-12 May 2010 |
Xavier Kurz - PROTECT - Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium - IMI JU - Safety Pillar, 3 May 2010 |
Jo Groves - PROTECT Project - EFPIA Patient Think-Tank Meeting, Brussels, 27 April 2010 |
Henry Fitt - Public-Private Partnerships in Europe and ENCePP Initiative - EuroMeeting of the Drug Information Association, Monaco, 8-10 March 2010 |
Liz Swain - PROTECT - Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium - EuroMeeting of the Drug Information Association, Monaco, 8-10 March 2010 |
| Xavier Kurz - PROTECT - Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium - Joint Meeting of the EMA’s Human Scientific Committees’ Working Party with Patients’ and Consumers’ Organisations and the Healthcare Professionals' Working Group, London, 5 March 2010 |
| PROTECT-IMI General Presentation |
| PROTECT general & status update - November 2011 |
| PROTECT Factsheet |
| Summary of Project Periodic Report Sep2009 - Aug2010 |
